Pyrazinamide and Epilepsy - a phase IV clinical study of FDA data

Summary:

Epilepsy is reported as a side effect among people who take Pyrazinamide (pyrazinamide), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Seromycin, and have Pulmonary tuberculosis.

The phase IV clinical study analyzes which people have Epilepsy when taking Pyrazinamide. It is created by eHealthMe based on reports of 10,019 people who have side effects when taking Pyrazinamide from the FDA, and is updated regularly.

What is Pyrazinamide?

Pyrazinamide has active ingredients of pyrazinamide. It is often used in tuberculosis. eHealthMe is studying from 10,062 Pyrazinamide users. Check the latest studies of Pyrazinamide.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,164 drugs and 1,778 conditions by eHealthMe. Check the latest studies of Epilepsy.

On Aug, 05, 2026

10,019 people reported to have side effects when taking Pyrazinamide.
Among them, 20 people (0.2%) have Epilepsy.

Among these 20 people:

How long have people been on Pyrazinamide when they have Epilepsy? *

What is the gender of people who have Epilepsy when taking Pyrazinamide? *

female: 47.37 %
male: 52.63 %

What is the age of people who have Epilepsy when taking Pyrazinamide? *

What are other drugs people take besides Pyrazinamide? *

What are other side effects people have besides Epilepsy? *

Weakness: 3 people, 15.00%
Anaemia (lack of blood): 2 people, 10.00%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 2 people, 10.00%
Hypoglycemia (low blood sugar): 2 people, 10.00%
Pulmonary Tuberculosis (lungs tuberculosis): 2 people, 10.00%
Memory Loss: 2 people, 10.00%
Weight Decreased: 1 person, 5.00%
Confusional State: 1 person, 5.00%
Drug Maladministration: 1 person, 5.00%
Dizziness: 1 person, 5.00%

What are the existing conditions these people have? *

Pulmonary Tuberculosis (lungs tuberculosis): 13 people, 65.00%
Tuberculoma Of Central Nervous System (a tumour-like mass that is not a cancer in brain, a complication of tuberculosis): 2 people, 10.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 5.00%
Hiv Test Positive: 1 person, 5.00%
Hiv Infection: 1 person, 5.00%
Disseminated Tuberculosis: 1 person, 5.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.00%
Abscess (pus): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pyrazinamide and have Epilepsy?

- Check whether Epilepsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pyrazinamide:

Pyrazinamide (10,062 reports)

Epilepsy treatments and more:

Epilepsy (129,285 reports)

Browse all side effects of Pyrazinamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy:

Epilepsy (1,164 drugs)

Browse all the conditions that are associated with Epilepsy:

Epilepsy (1,778 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pyrazinamide (the active ingredients of Pyrazinamide) and Pyrazinamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.